Wei-Ting Chang Selected Research

Wei-Ting Chang Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 06/2011
17	Heart Failure 03/2024 - 05/2019
11	Cardiotoxicity 01/2024 - 09/2016
10	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2016
10	Fibrosis (Cirrhosis) 11/2023 - 12/2016
7	Hypertension (High Blood Pressure) 01/2023 - 01/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2020
6	Hypertrophy 06/2023 - 11/2018
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 04/2015
4	Diabetes Mellitus 01/2024 - 03/2020
4	Myocardial Infarction 01/2023 - 11/2015
4	Hypoxia (Hypoxemia) 01/2022 - 11/2018
4	COVID-19 11/2021 - 12/2020
4	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2017
3	Chronic Renal Insufficiency 03/2024 - 09/2022
3	ST Elevation Myocardial Infarction 01/2024 - 01/2017
3	Pulmonary Arterial Hypertension 12/2023 - 01/2021
3	Congenital Heart Defects (Congenital Heart Defect) 12/2023 - 12/2019
3	Mitral Valve Insufficiency (Mitral Regurgitation) 11/2023 - 01/2021
3	Acute Coronary Syndrome 11/2023 - 01/2017
3	Hemorrhage 09/2022 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2022
3	Inflammation (Inflammations) 11/2021 - 01/2015
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2020 - 11/2019
3	Thrombosis (Thrombus) 10/2020 - 01/2017
3	Hyperglycemia 01/2019 - 12/2016
2	Obesity 12/2023 - 10/2023
2	Kidney Diseases (Kidney Disease) 11/2023 - 01/2020
2	Atrial Fibrillation 01/2023 - 06/2021
2	Cardiac Arrhythmias (Arrythmia) 01/2023 - 01/2021
2	Ischemic Stroke 01/2023 - 09/2022
2	Lung Neoplasms (Lung Cancer) 01/2023 - 10/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2023
2	Acute Kidney Injury (Acute Renal Failure) 10/2022 - 10/2021
2	Dyspnea (Shortness of Breath) 10/2022 - 09/2016
2	Thromboembolism 09/2022 - 01/2022
2	Venous Thromboembolism 09/2022 - 01/2021
2	Pulmonary Embolism 09/2022 - 04/2020
2	Pulmonary Hypertension 09/2022 - 12/2019
2	Hypersensitivity (Allergy) 11/2021 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2018
2	Myocarditis (Carditis) 01/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 11/2013 - 10/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2024
1	Liver Diseases (Liver Disease) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Overweight 10/2023
1	Amyloidosis 07/2023
1	Restrictive Cardiomyopathy 07/2023

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2015
7	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2018
6	dapagliflozinIBA 11/2023 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
5	AnticoagulantsIBA 01/2023 - 10/2019
4	AnthracyclinesIBA 01/2024 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 01/2023
3	Trastuzumab (Herceptin)FDA Link 01/2024 - 12/2021
3	Cardiovascular AgentsIBA 01/2023 - 01/2022
3	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2016
3	Angiotensin Receptor AntagonistsIBA 05/2022 - 12/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2022 - 01/2022
3	CytokinesIBA 11/2021 - 01/2015
3	alpha-2-HS-GlycoproteinIBA 01/2017 - 04/2015
2	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 01/2022
2	Sodium-Glucose Transport ProteinsIBA 01/2024 - 01/2023
2	SodiumIBA 11/2023 - 12/2022
2	Vitamin K FDA Link 01/2023 - 09/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2023
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2023
2	RivaroxabanIBA 09/2022 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 01/2020
2	Angiotensin IIIBA 07/2022 - 01/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2022 - 01/2021
2	Epirubicin (Ellence)FDA LinkGeneric 04/2022 - 09/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Conditioned Culture MediaIBA 11/2021 - 11/2018
2	Insulin (Novolin)FDA Link 01/2021 - 01/2018
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021 - 12/2016
2	LipidsIBA 03/2020 - 01/2018
2	CalcineurinIBA 01/2019 - 01/2019
2	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 11/2018 - 12/2016
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2018 - 12/2016
2	Telmisartan (Micardis)FDA Link 01/2018 - 12/2016
2	VaccinesIBA 09/2015 - 06/2011
2	Arabinofuranosyluracil (Ara U)IBA 11/2013 - 10/2011
1	A-factor (Streptomyces)IBA 01/2024
1	Cytochrome P-450 CYP2C19IBA 12/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	Carvedilol (Coreg)FDA LinkGeneric 11/2023
1	IvabradineIBA 11/2023
1	Amyloid (Amyloid Fibrils)IBA 07/2023
1	Prealbumin (Transthyretin)IBA 07/2023

Therapy/Procedure

21	Therapeutics 01/2024 - 04/2013
6	Drug Therapy (Chemotherapy) 01/2023 - 09/2016
3	Percutaneous Coronary Intervention 01/2024 - 11/2015
2	Subacute Care 03/2024 - 05/2019
2	Length of Stay 01/2024 - 01/2013
2	Immunotherapy 09/2015 - 01/2013